InterMune: Clinical Trials

10 trials sponsored by InterMune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 10
Phase 12Completed 2

Follow InterMune: new trials by email

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
5-Fluorouracil, Leucovorin (LV), Gamma-Interferon-1b (IFN-γ) - Colorectal Cancer
Phase 2CompletedAccelerated Community Oncology Research Network482006-02-012012-03-01
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug) - Hepatitis C, Chronic
Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis652004-06-012007-08-30
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)
Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirin - Chronic Hepatitis C
Phase 2CompletedInterMune812004-04-012009-07-03
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
Carboplatin, GM-CSF (Sargramostim), Interferon Gamma - Ovarian Cancer, Fallopian Tube Cancer
Phase 2CompletedM.D. Anderson Cancer Center592003-01-012012-08-07
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
interferon-gamma 1b - Lung Disease, Pulmonary Fibrosis
Phase 2CompletedInterMune2102002-09-012007-11-06
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune512002-04-012007-11-01
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Interferon-gamma 1b - Idiopathic Pulmonary Fibrosis
Phase 2CompletedInterMune322001-11-012007-11-06
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
interferon gamma-1b - Liver Fibrosis, Cirrhosis
Phase 2CompletedInterMune5022001-09-012007-11-01
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune662001-02-012007-11-01
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Itraconazole, Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedInterMune602000-01-012009-06-03

Conditions studied

Cystic Fibrosis (2)  ·  Hepatitis C, Chronic (2)  ·  Idiopathic Pulmonary Fibrosis (2)  ·  Colorectal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Fibrosis (1)  ·  HIV Infections (1)  ·  Hepatitis C (1)  ·  Liver Cirrhosis (1)  ·  Lung Diseases (1)  ·  Meningitis, Cryptococcal (1)  ·  Ovarian Neoplasms (1)  ·  Pulmonary Fibrosis (1)

Interventions

interferon gamma-1b (6)  ·  Interferon-gamma (5)  ·  Ribavirin (2)  ·  Amphotericin B (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Fluconazole (1)  ·  Flucytosine (1)  ·  Fluorouracil (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Itraconazole (1)  ·  Leucovorin (1)  ·  Pharmaceutical Preparations (1)  ·  sargramostim (1)

Countries

United States (7)  ·  France (1)  ·  Peru (1)

Top investigators

Steven Porter, MD (2)  ·  Javier Szwarcberg, MD (1)  ·  Lee Schwartzberg, MD (1)  ·  Matthew McClure, MD (1)  ·  Patrice Couzigou, MD, PhD (1)  ·  Ralph Freedman, MD, PhD (1)  ·  Steve Porter, MD (1)  ·  Williamson Bradford, MD (1)

Results publications

PMID 19264351, PMID 23190183

NIH funding

2004 (1)